M. Rasmussen

An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome

I. Bernstein, L. Jensen, C. Therkildsen, 2021, Clinical and experimental gastroenterology.

Immunohistochemical screening of upper tract urothelial carcinomas for Lynch syndrome diagnostics: a systematic review.

C. Therkildsen, M. G. Madsen, M. Rasmussen, 2022, Urology.

Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort

L. Lindberg, M. Nilbert, T. Kallemose, 2020, BMC Cancer.

Benefit from extended surveillance interval on colorectal cancer risk in Lynch syndrome

L. Lindberg, M. Nilbert, K. K. Andersen, 2019, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Response to Immune Checkpoint Inhibitors Is Affected by Deregulations in the Antigen Presentation Machinery: A Systematic Review and Meta-Analysis

J. A. Durhuus, M. Nilbert, C. Therkildsen, 2022, Journal of clinical medicine.

Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors

M. Santibanez-Koref, J. Burn, J. A. Durhuus, 2023, Frontiers in Oncology.

Lynch syndrome-associated epithelial ovarian cancer and its immunological profile.

I. Svane, L. Jensen, Kevin Lim, 2021, Gynecologic Oncology.